Results 231 to 240 of about 212,254 (386)

Gastric biopsies with prominent eosinophils: Clinicopathologic features and response to therapy. [PDF]

Histopathology
The use of the term ‘histologic eosinophilic gastritis’ (EoG) has been proposed for cases with ≥30 eosinophils/high power field (HPF) in five separate HPF and with no known associated causes of eosinophilia; however, these criteria can miss cases with clinically significant eosinophilia and our study results argue against using this term for pathology ...
Khurram NA, Kakar S, Balitzer D.
europepmc   +2 more sources

Relative efficacy of GLP‐1 and GLP‐1/GIP receptor agonists in the prevention of alcohol‐use disorders using a target trial emulation approach

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 137-150, January 2026.
Abstract Aims There is growing evidence that the GLP‐1 system is implicated in alcohol and other substance use disorders, and that GLP‐1‐based therapies may have therapeutic relevance in alcohol use disorder (AUD). We aimed to determine the impact of GLP‐1 based therapies on incident AUDs in a real‐world setting in patients with T2D.
Alex E. Henney, David R. Riley, Megan Heague, Carl A. Roberts, Theresa J. Hydes, Matthew Anson, David M. Hughes, Uazman Alam, Daniel J. Cuthbertson   +8 more
wiley   +1 more source

Improvement in Chronic Atrophic Gastritis After Treatment with Zinc L-Carnosine. [PDF]

Am J Case Rep
De Bastiani R, Fassan M, Businello G, Tursi A.   +3 more
europepmc   +1 more source

EVALUASI PROSES KEPERAWATAN PADA PASIEN GASTRITIS

, 2019
Adelia Devita Sari
openalex   +1 more source

Expression and cellular localization of COX‐1 and ‐2 in Helicobacter pylori gastritis [PDF]

, 2001
Francis K.L. Chan, Ka‐Fai To, Yu Pong Ng, TL Lee, Alfred S.L. Cheng, Wai K. Leung, Joseph J.�Y. Sung   +6 more
openalex   +1 more source

Lobeglitazone improves glycaemic control as add‐on therapy to empagliflozin plus metformin in patients with type 2 diabetes mellitus: A double‐blind, randomised, placebo‐controlled trial

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 728-740, January 2026.
Abstract Aims This study aimed to evaluate the efficacy and safety of triple therapy with lobeglitazone 0.5 mg as an add‐on treatment compared with placebo in patients with type 2 diabetes mellitus (T2DM) inadequately controlled with metformin and empagliflozin.
Da Hea Seo, Kyung Wan Min, Ho Sang Sohn, Sang Yong Kim, In‐Kyung Jeong, Cheol‐Young Park, Kun‐Ho Yoon, So Hun Kim, Bong‐Soo Cha   +8 more
wiley   +1 more source

Inhibition of microRNA-155 regulates gastric mucosal barrier repair and inflammation by targeting SOCS1 for the treatment of acute gastritis. [PDF]

Sci Rep
Luo L, Zhang K, Mu S, Liu S, Xiao W, Liu X.   +5 more
europepmc   +1 more source

Short‐Term Alcohol Consumption Is Sufficient to Disrupt Microbial Communities and the Intestinal and Circulating Metabolites in a Non‐Human Primate Model

The FASEB Journal, Volume 39, Issue 23, 15 December 2025.
This study assessed the impact of short‐term (6 months) voluntary ethanol self‐administration on the composition of the gut microbiome as well as fecal and circulating metabolomes using a non‐human primate model. We demonstrate that short‐term ethanol consumption increased the abundance of microbes associated with inflammation resolution, while ...
Madison B. Blanton, Ethan G. Napier, Katelyn E. Keen, Ethan V. Stuart, Isaac R. Cinco, Hami Hemati, Ronald C. Bruntz, Rupak Khadka, Kathleen A. Grant, Ilhem Messaoudi   +9 more
wiley   +1 more source

Dietary Inflammatory Index and the Risk of Gastric Precancerous Lesions Among Korean Adults in a Rural Area. [PDF]

Nutrients
Cho Y, Lee D, Eun CS, Han DS, Kim HJ.
europepmc   +1 more source

Advancing Clinical Medicine with Raman Spectroscopy: Current Trends and Future Perspectives

Advanced Photonics Research, Volume 6, Issue 12, December 2025.
Raman spectroscopy and microscopy may become excellent tools in clinical medicine, including hematology, oncology, infectious diseases, neurology, gastroenterology, reproductive medicine, rheumatology, and cardiovascular research. However, many challenges such as signal interference, standardization issues, and limited clinical application need to be ...
Jiří Bufka, Lenka Vaňková, Josef Sýkora, Věra Křížková, Jan Schwarz, Petr Bouř   +5 more
wiley   +1 more source